Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gach

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Biotechnology|February 3, 2007
High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastorisJohannes S Gach, Michael Maurer, Rainer Hahn, et al.
Oncoimmunology|May 12, 2015
Anti-p21 autoantibodies detected in colorectal cancer patients: A proof of concept studyFaraz Bishehsari, Johannes S Gach, Naomi Akagi, et al.
The Journal of Biological Chemistry|November 12, 2009
Proline is not uniquely capable of providing the pivot point for domain swapping in 2G12, a broadly neutralizing antibody against HIV-1Johannes S Gach, Paul G Furtmüller, Heribert Quendler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2010
Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12Donald N Forthal, Johannes S Gach, Gary Landucci, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 14, 2025
Detection and Validation of Influenza Virus Hemagglutinin Specific, Cross-Reactive, and Heteroclitic B Cells Induced by a Combination Vaccine AdjuvantEgest J Pone, Jiin Felgner, Jenny Hernandez-Davies, et al.
Journal of Molecular Biology|October 29, 2011
Structure-based design of a protein immunogen that displays an HIV-1 gp41 neutralizing epitopeRobyn L Stanfield, Jean-Philippe Julien, Robert Pejchal, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
SARS-CoV-2 virus infection of <i>Peromyscus leucopus</i> demonstrates that infection tolerance is not limited to agents for which deermice are reservoirsAna Milovic, Johannes S Gach, Ioulia Chatzistamou, et al.
Biomedizinische Technik. Biomedical Engineering|February 13, 2019
Session 1: Young scientist forumS Janßen, S Gach, S Neuss-Stein, et al.
Plos One|May 5, 2015
A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant AntigensEmmanuel Y Dotsey, Andrea Gorlani, Sampat Ingale, et al.
Cellular Immunology|February 23, 2023
Vaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cellsJee Young Chung, Melissa N Thone, Jenny E Davies, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Biotechnology|February 3, 2007
High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastorisJohannes S Gach, Michael Maurer, Rainer Hahn, et al.
Oncoimmunology|May 12, 2015
Anti-p21 autoantibodies detected in colorectal cancer patients: A proof of concept studyFaraz Bishehsari, Johannes S Gach, Naomi Akagi, et al.
The Journal of Biological Chemistry|November 12, 2009
Proline is not uniquely capable of providing the pivot point for domain swapping in 2G12, a broadly neutralizing antibody against HIV-1Johannes S Gach, Paul G Furtmüller, Heribert Quendler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2010
Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12Donald N Forthal, Johannes S Gach, Gary Landucci, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 14, 2025
Detection and Validation of Influenza Virus Hemagglutinin Specific, Cross-Reactive, and Heteroclitic B Cells Induced by a Combination Vaccine AdjuvantEgest J Pone, Jiin Felgner, Jenny Hernandez-Davies, et al.
Journal of Molecular Biology|October 29, 2011
Structure-based design of a protein immunogen that displays an HIV-1 gp41 neutralizing epitopeRobyn L Stanfield, Jean-Philippe Julien, Robert Pejchal, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
SARS-CoV-2 virus infection of <i>Peromyscus leucopus</i> demonstrates that infection tolerance is not limited to agents for which deermice are reservoirsAna Milovic, Johannes S Gach, Ioulia Chatzistamou, et al.
Biomedizinische Technik. Biomedical Engineering|February 13, 2019
Session 1: Young scientist forumS Janßen, S Gach, S Neuss-Stein, et al.
Plos One|May 5, 2015
A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant AntigensEmmanuel Y Dotsey, Andrea Gorlani, Sampat Ingale, et al.
Cellular Immunology|February 23, 2023
Vaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cellsJee Young Chung, Melissa N Thone, Jenny E Davies, et al.
Pageof 5